（START up X） RNA医薬品、日本にも種　　大学発、供給網の構築課題 | AN Venture Partners

（START up X） RNA医薬品、日本にも種　　大学発、供給網の構築課題

MediaPortfolio Companies

（START up X） RNA医薬品、日本にも種　　大学発、供給網の構築課題

March 27, 2024

Crystalys Therapeutics Closes $130 Million Series B Funding to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout

Press Release

Portfolio Companies

Crystalys Therapeutics Closes $130 Million Series B Funding to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout

San Diego, July 23, 2026

City Therapeutics Announces $99.5 Million Series B Financing to Advance Next-Generation RNAi Therapeutics

Press Release

Portfolio Companies

City Therapeutics Announces $99.5 Million Series B Financing to Advance Next-Generation RNAi Therapeutics

Cambridge, Mass., June 19, 2026

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.